VUB SPIN-OFF HEADLINES IN THE PRESS IN 2022

VIB-VUB spin-off Animab raises €10 million for further development of edible antibodies

November 2022 – Source De Tijd & VIB News

New VUB-imec spin-off Swave Photonics, an innovator in Holographic eXtended Reality (HXR) technology to bring the metaverse to life, announced a €7 million seed round.

June 2022 – Source De Tijd

Precirix raises €80M in Series B to advance its pipeline of precision radiopharmaceuticals

March 2022 – Source De Tijd

New personalized cancer vaccine in the making thanks to unique Belgian collaboration. The Belgian start-up Persomed was founded in 2020 in collaboration with VUB and 3 other partners. All of whom have expertise within the field of personalized immunotherapy.

November 2022 – Source Biovox

Weave.ly, a VUB spin-off, has completed a first capital round of € 300.000.

September 2022 – Source Start it Accelerate

39M euro invested in VUB spinoff eTheRNA to boost mRNA therapeutics

September 2022 – Source De Tijd

Confo Therapeutics, a VIB-VUB spin-off, doses first subjects in Phase 1 clinical trial to develop a non-opioid approach to the treatment of neuropathic pain.

March 2022 – Source flanders.bio

VUB and UZ Brussel spin-off Lavima Fertility develops new fertility treatment

March 2022 – Source Bruzz, EOS

VUB spin-off Axiles Bionics wins the Innovative Starters Award 2021, granted in 2022, and receives 500.000 euro from Innoviris.

February 2022 – Source innoviris.brussels eTheRNA announces research agreement with Merck to access mRNA technologies

February 2022 – Source flanders.bio

Want to launch your own spin-off?

A video was made in 2022 to encourage researchers to contact VUB TechTransfer to support them in starting a VUB spin-off.